Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (vol 54, pg 44, 2011)

Y. Miao; D. Dobre; H. J. Lambers Heerspink; B. M. Brenner; M. E. Cooper; H. -H. Parving; S. Shahinfar; D. Grobbee; D. de Zeeuw

doi:10.1007/s00125-011-2215-4

Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (vol 54, pg 44, 2011)

Y. Miao, D. Dobre, H. J. Lambers Heerspink^*, B. M. Brenner, M. E. Cooper, H. -H. Parving, S. Shahinfar, D. Grobbee, D. de Zeeuw

^*Corresponding author for this work

Groningen Kidney Center (GKC)

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	2209-2209
Number of pages	1
Journal	Diabetologia
Volume	54
Issue number	8
DOIs	https://doi.org/10.1007/s00125-011-2215-4
Publication status	Published - Aug-2011

Access to Document

10.1007/s00125-011-2215-4

Handle.net

Persistent link

Cite this

Miao, Y., Dobre, D., Lambers Heerspink, H. J., Brenner, B. M., Cooper, M. E., Parving, H. .-H., Shahinfar, S., Grobbee, D., & de Zeeuw, D. (2011). Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (vol 54, pg 44, 2011). Diabetologia, 54(8), 2209-2209. https://doi.org/10.1007/s00125-011-2215-4

@article{cec369e4db764d48bcb87c1abaa708b8,

title = "Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (vol 54, pg 44, 2011)",

author = "Y. Miao and D. Dobre and {Lambers Heerspink}, {H. J.} and Brenner, {B. M.} and Cooper, {M. E.} and Parving, {H. -H.} and S. Shahinfar and D. Grobbee and {de Zeeuw}, D.",

year = "2011",

month = aug,

doi = "10.1007/s00125-011-2215-4",

language = "English",

volume = "54",

pages = "2209--2209",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer",

number = "8",

}

Miao, Y, Dobre, D, Lambers Heerspink, HJ, Brenner, BM, Cooper, ME, Parving, H-H, Shahinfar, S, Grobbee, D & de Zeeuw, D 2011, 'Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (vol 54, pg 44, 2011)', Diabetologia, vol. 54, no. 8, pp. 2209-2209. https://doi.org/10.1007/s00125-011-2215-4

Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (vol 54, pg 44, 2011). / Miao, Y.; Dobre, D.; Lambers Heerspink, H. J. et al.
In: Diabetologia, Vol. 54, No. 8, 08.2011, p. 2209-2209.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Increased serum potassium affects renal outcomes

T2 - a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (vol 54, pg 44, 2011)

AU - Miao, Y.

AU - Dobre, D.

AU - Lambers Heerspink, H. J.

AU - Brenner, B. M.

AU - Cooper, M. E.

AU - Parving, H. -H.

AU - Shahinfar, S.

AU - Grobbee, D.

AU - de Zeeuw, D.

PY - 2011/8

Y1 - 2011/8

U2 - 10.1007/s00125-011-2215-4

DO - 10.1007/s00125-011-2215-4

M3 - Article

SN - 0012-186X

VL - 54

SP - 2209

EP - 2209

JO - Diabetologia

JF - Diabetologia

IS - 8

ER -